# FDA Inspection 1160099 - K.D. Pharma Bexbach GmbH - May 14, 2020

Source: https://www.keypedia.com/records/fda_inspections/kd-pharma-bexbach-gmbh/8bbb953d-0615-4cfc-a89f-ef3924aea961
Source feed: FDA_Inspections

> FDA Inspection 1160099 for K.D. Pharma Bexbach GmbH on May 14, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1160099
- Company Name: K.D. Pharma Bexbach GmbH
- Inspection Date: 2020-05-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1289824 - 2023-04-19](https://www.keypedia.com/records/fda_inspections/kd-pharma-bexbach-gmbh/144d4319-47d4-41d2-86d5-5c5dd46430d7)
- [FDA Inspection 1020492 - 2017-06-16](https://www.keypedia.com/records/fda_inspections/kd-pharma-bexbach-gmbh/e69186d5-3db4-41ff-9ef6-4923fac0f043)
- [FDA Inspection 779536 - 2012-03-20](https://www.keypedia.com/records/fda_inspections/kd-pharma-bexbach-gmbh/6e069838-ab97-47a1-b3aa-2ebf75630431)

Company: https://www.keypedia.com/companies/kd-pharma-bexbach-gmbh/aadaacb5-a79c-43e0-be6e-7f8f8f54d014

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c